Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers
Status:
Active, not recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The pharmacokinetics, safety, and tolerability of meloxicam eye drops in Chinese healthy
volunteers were evaluated to provide a basis for the formulation of a phase II clinical trial
dosing regimen for this product. Including pre-tests and formal trials, formal trials include
single-dose pharmacokinetics tests and multiple-dose tolerance tests (4 times a day for 3
consecutive days).